S
SGMOQ//CIK 0001001233
SANGAMO THERAPEUTICS, INC
Market Data
$0.07−$0.10 (−58.82%)
SGMOQ · Last trade
Prev Close
$0.17
Range (28d)
$0.04 – $0.17
Recent Filings
- 8-K139.7 KBSANGAMO THERAPEUTICS, INCJul 20, 4:44 PM ET·0001193125-26-309012
- 8-K143.2 KBSANGAMO THERAPEUTICS, INCJul 1, 4:01 PM ET·0001193125-26-292501
- 8-K/A1.1 MBSANGAMO THERAPEUTICS, INCJun 23, 4:42 PM ET·0001193125-26-279630
- 8-K169.1 KBSANGAMO THERAPEUTICS, INCJun 23, 8:45 AM ET·0001193125-26-278582
- 10-Q4.4 MBSANGAMO THERAPEUTICS, INCMay 14, 4:03 PM ET·0001628280-26-035067
- 8-K301.8 KBSANGAMO THERAPEUTICS, INCMay 14, 4:02 PM ET·0001628280-26-035061
- 8-K148.4 KBSANGAMO THERAPEUTICS, INCApr 29, 8:37 AM ET·0001628280-26-028128
- 10-K34.8 MBSANGAMO THERAPEUTICS, INCMar 30, 5:31 PM ET·0001628280-26-022029
- 8-K326.9 KBSANGAMO THERAPEUTICS, INCMar 30, 5:29 PM ET·0001628280-26-022006
- 8-K658.1 KBSANGAMO THERAPEUTICS, INCFeb 4, 8:35 AM ET·0001193125-26-036792
Insiders
10- ANDO DALE GVP, Therapeutic Dev. & CMO
- Beers CourtneyDirector
- BIOGEN INC.10% Owner
- BLUFORD PETERVP, Corporate Development
- Boissel StephaneEVP, Corporate Strategy
- Carey RobertDirector
- CASE CASEY CVP, Research & Operations
- Cleveland Paul BDirector
- Conner Edward R.Senior VP & CMO
- Davis Gregory DHead of Research & Technology
Tickers
Addresses
business
501 CANAL BLVD.
RICHMOND, CA, 94084
mailing
501 CANAL BLVD.
RICHMOND, CA, 94084
Former Names
- SANGAMO BIOSCIENCES INC2017-01-06